|
ZNF542 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.13120000000411E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.08629999999266E-05 |
| Normal-vs-Stage2 |
4.397100E-03 |
| Normal-vs-Stage3 |
3.62460000002951E-06 |
| Normal-vs-Stage4 |
4.00939999978256E-07 |
| Stage1-vs-Stage2 |
6.786000E-01 |
| Stage1-vs-Stage3 |
1.777370E-01 |
| Stage1-vs-Stage4 |
3.660000E-02 |
| Stage2-vs-Stage3 |
2.213400E-01 |
| Stage2-vs-Stage4 |
5.157500E-02 |
| Stage3-vs-Stage4 |
3.636000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.79480000043142E-07 |
| Normal-vs-AfricanAmerican |
5.759600E-02 |
| Normal-vs-Asian |
3.724400E-03 |
| Caucasian-vs-AfricanAmerican |
2.250600E-01 |
| Caucasian-vs-Asian |
2.451600E-01 |
| AfricanAmerican-vs-Asian |
7.479200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.96485999999219E-05 |
| Normal-vs-Female |
2.37999999996852E-06 |
| Male-vs-Female |
9.808000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.53046999999962E-05 |
| Normal-vs-Age(41-60Yrs) |
7.94360000000438E-05 |
| Normal-vs-Age(61-80Yrs) |
3.80130000032786E-07 |
| Normal-vs-Age(81-100Yrs) |
1.501780E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.905000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.792780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.325200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.721390E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.129200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.601800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.072400E-02 |
| Classical-VS-Follicular |
5.525700E-02 |
| Classical-VS-Other |
6.753600E-01 |
| Classical-VS-Normal |
1.410270E-04 |
| Tall-VS-Follicular |
6.134600E-01 |
| Tall-VS-Other |
6.012200E-01 |
| Tall-VS-Normal |
5.60239999999324E-05 |
| Follicular-VS-Other |
8.326000E-01 |
| Follicular-VS-Normal |
1.53761999999169E-05 |
| Other-VS-Normal |
6.463700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.84468999999687E-05 |
| Normal-vs-N1 |
4.08380000038733E-07 |
| N0-vs-N1 |
6.218100E-02 |
|
|
